Evidence map›Paper›PMID 23846179›Full record

ArticleFly

A method for reversible drug delivery to internal tissues of Drosophila embryos.

Victoria K Schulman, Eric S Folker, Mary K Baylies

Open access · bronzeAbstract read
In one paragraph

Article in Fly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Exploiting the Potential ofBiomedicines · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Imaging Approaches to Investigate Myonuclear Positioning in Drosophila.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Morphogenesis of the somatic musculature in Drosophila melanogaster.Wiley interdisciplinary reviews. Developmental biology
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Victoria K SchulmanProgram in Developmental Biology; Sloan Kettering Institute; Memorial Sloan-Kettering Cancer Center; New York, NY USA; Department of Cell and Developmental Biology; Weill Cornell Graduate School of Medical Sciences; Cornell University; New York, NY USA.
Eric S Folker
Mary K Baylies
Cornell University · USKettering University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Mechanisms Regulating Myoblast Fusion in DrosophilaR01GM078318 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI BAYLIES, MARY K · 2007 to 2010
$2.0M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM078318
6 · The paper itself

Abstract

Drosophila melanogaster is a powerful model organism to elucidate basic cellular mechanisms of development. Indeed, much of our understanding of genetic pathways comes from work in Drosophila. However, mutations in many critical genes cause early embryonic lethality; thus, it is difficult to study the role of proteins that are required for early fundamental processes during later embryonic stages. We have therefore developed a method to reversibly deliver drugs to internal tissues of stage 15-16 Drosophila embryos using a 1:1 combination of D-limonene and heptane (LH). Specifically, delivery of Nocodazole was shown to be effective as evidenced by the significant decrease in microtubule density seen in muscle cells. Following complete depolymerization of the microtubule cytoskeleton, removing the Nocodazole and washing for 10 min was sufficient for the microtubule network to be re-established, indicating that drug delivery is reversible. Additionally, the morphology of LH-treated embryos resembled that of untreated controls, and embryo viability post-treatment with LH was significantly increased compared with previously reported permeabilization techniques. These advances in embryo permeabilization provide a means to disrupt protein function in vivo with high temporally specificity, bypassing the complications associated with genetic disruptions as they relate to the study of late-stage developmental mechanisms.

Indexed as

AnimalsCyclohexenesDrosophilaDrug CombinationsDrug Delivery SystemsEmbryo, NonmammalianHeptanesLimoneneMusclesNocodazolePermeabilityTerpenesCyclohexenesDrug CombinationsHeptanesLimoneneNocodazoleTerpenesChorionDrosophiladrug deliveryembryopermeabilization

Identifiers

PMID23846179
PMCPMC4049853
OpenAlexW2086575286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.